Cardiovascular Evaluation Before Renal Transplantation
Cardiovascular Diagnostic Before Renal Transplantation: a Prospective Study to Assess Cardiovascular Morbidity Before Renal Transplantation and to Improve Standard Diagnostic Procedures.
2 other identifiers
observational
100
1 country
1
Brief Summary
Due to rising importance of cardiovascular disease before and after renal transplantation we have changed our standard diagnostic procedure and perform stress echocardiography and myocardial scintigraphy. We would like to monitor these results and the outcome of our patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2009
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2009
CompletedFirst Submitted
Initial submission to the registry
February 5, 2010
CompletedFirst Posted
Study publicly available on registry
February 8, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2010
CompletedFebruary 8, 2010
January 1, 2010
6 months
February 5, 2010
February 5, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
cardiovascular morbidity
one year
Study Arms (1)
before renal transplantation
Patients with CKD IV° to V° who are actually registering for a renal transplantation in our department.
Interventions
Cardiovascular diagnostic standard procedure before renal transplantation using stress echocardiography and stress myocardial scintigraphy.
Eligibility Criteria
All patients with endstage renal disease which are awaiting their ergsitration to our transplantation programm since July 2009 until July 2010.
You may qualify if:
- endstage renal disease
- preparing for renal transplantation
You may not qualify if:
- children (\< 18 years)
- women who are pregnant or nursing
- patients who are also awaiting heart transplantation or have already a heart transplant
- severe mental illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Internal Medicine D, University Hospital Muenster
Münster, 48149, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barbara Suwelack, MD
University Hospital Muenster
- STUDY CHAIR
Hermann Pavenstädt, MD
University Hospital Muenster
- STUDY CHAIR
Holger Reinecke, MD
University Hospital Muenster
- STUDY CHAIR
Otmar Schober, MD, PhD
University Hospital Muenster
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 5, 2010
First Posted
February 8, 2010
Study Start
December 1, 2009
Primary Completion
June 1, 2010
Study Completion
September 1, 2010
Last Updated
February 8, 2010
Record last verified: 2010-01